(Q50896818)

24 March 2018

title

Dynamical properties of a minimally parameterized mathematical model for metronomic chemotherapy. (English)

1 reference

24 March 2018

1 reference

1 reference

2

Urszula Ledzewicz

1 reference

24 March 2018

author name string

Heinz Schättler

series ordinal

1

1 reference

24 March 2018

Behrooz Amini

series ordinal

3

1 reference

24 March 2018

publication date

19 June 2015

1 reference

24 March 2018

number of pages

26

1 reference

Journal of Mathematical Biology

inferred from page(s)

published in

1 reference

24 March 2018

volume

72

1 reference

24 March 2018

issue

5

1 reference

24 March 2018

page(s)

1255-1280

1 reference

24 March 2018

maintained by WikiProject

WikiProject Mathematics

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s00285-015-0907-y

0 references

cites work

Metronomic scheduling of anticancer treatment: the next generation of multitarget therapy?

1 reference

https://api.crossref.org/works/10.1007%2FS00285-015-0907-Y

Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00285-015-0907-Y

Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00285-015-0907-Y

A family of models of angiogenesis and anti-angiogenesis anti-cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00285-015-0907-Y

On optimal delivery of combination therapy for tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00285-015-0907-Y

Dynamic response of cancer under the influence of immunological activity and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00285-015-0907-Y

Interactions between the immune system and cancer: a brief review of non-spatial mathematical models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00285-015-0907-Y

Tumor cells proliferation and migration under the influence of their microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00285-015-0907-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00285-015-0907-Y

Nonlinear Oscillations, Dynamical Systems, and Bifurcations of Vector Fields

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00285-015-0907-Y

Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00285-015-0907-Y

Minimizing long-term tumor burden: the logic for metronomic chemotherapeutic dosing and its antiangiogenic basis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00285-015-0907-Y

Interaction of tumor with its micro-environment: A mathematical model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00285-015-0907-Y

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00285-015-0907-Y

Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00285-015-0907-Y

The role of cell density and intratumoral heterogeneity in multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00285-015-0907-Y

Optimal response to chemotherapy for a mathematical model of tumor-immune dynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00285-015-0907-Y

On optimal chemotherapy with a strongly targeted agent for a model of tumor-immune system interactions with generalized logistic growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00285-015-0907-Y

Metronomic chemotherapy: new rationale for new directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00285-015-0907-Y

A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00285-015-0907-Y

Robustness of optimal controls for a class of mathematical models for tumor anti-angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00285-015-0907-Y

On mathematical modeling of critical variables in cancer treatment (goals: better understanding of the past and better planning in the future).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00285-015-0907-Y

Immune surveillance of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00285-015-0907-Y

The tumor microenvironment and its role in promoting tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00285-015-0907-Y

A general framework for modeling tumor-immune system competition and immunotherapy: Mathematical analysis and biomedical inferences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00285-015-0907-Y

The angiopoietins: Yin and Yang in angiogenesis

21 January 2018

1 reference

12 December 2020

Optimal Scheduling of Radiotherapy and Angiogenic Inhibitors

1 reference

12 December 2020

High-time chemotherapy or high time for low dose

1 reference

12 December 2020

Back to the basics: the importance of concentration x time in oncology

1 reference

12 December 2020

Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs.

1 reference

12 December 2020

Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy

1 reference

12 December 2020

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer

1 reference

12 December 2020

Tumor size, sensitivity to therapy, and design of treatment schedules

1 reference

12 December 2020

A validated mathematical model of cell-mediated immune response to tumor growth.

1 reference

12 December 2020

10.1007/S00285-015-0907-Y

Identifiers

DOI

1 reference

24 March 2018

1 reference

24 March 2018